Navigation Links
Lilly Reports Fourth-Quarter and Full-Year 2009 Results
Date:1/28/2010

tion - .13 Asset impairments and restructuring charges (included in asset impairments, restructuring and other special charges) - .29 In-process research and development charge associated with Incyte licensing agreement - .05 -------------- -------------- Earnings per share (non-GAAP) $4.65 to $4.85 $4.42 5% to 10% -------------- --------------

Numbers in the 2009 column do not add due to rounding.

The company expects volume-driven revenue growth in the high-single digits, driven primarily by Alimta, Cymbalta, Humalog, Cialis, Effient and the exenatide franchise.

The company anticipates that gross margin as a percent of revenue will be flat to declining. Excluding the effect of foreign exchange rates on international inventories sold, the company expects gross margin as a percent of revenue to increase.

Marketing, selling and administrative expenses are projected to grow in the low- to mid-single digits while research and development expenses are projected to grow in the low-double digits.

Other income is expected to be a net expense of between $150.0 and $200.0 million, and the tax rate is expected to be approximately 22 percent.

Cash flows are expected to be sufficient to fund capital expenditures of approximately $1.0 billion, anticipated business development activity and the company's dividend.

Webcast of Conference Call

As previously announced, investors and the general public can access a live webcast of the fourth-quarter and full-year 2009 financial results conference call through a link on Lilly's website at

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
3. Lilly and Glenmark Pharmaceuticals Announce License Agreement
4. Lilly Receives NCQA Design Certification for Depression Care Management Program
5. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
7. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
8. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
9. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
10. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
11. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... The Pharmaceutical Care Management Association (PCMA) ... D offsets included in the Energy & Commerce ... the 21st Century Cures initiative can only be advanced ... – Medicare – then its costs outweigh any ... "Leveraging payments to Part D plans ...
(Date:5/21/2015)... 21, 2015 ... Zwecks Leistungsvergleich zur Expertise und zum ... verwiesen, in denen uneingeschränkt betriebsfähige Systeme, ... ein Aegate-Land: beispielsweise BELGIEN   ... von Arzneimittelfälschungen (FMD) handelt es sich ...
(Date:5/21/2015)... May 21, 2015 In praising today,s ... legislation by the House Energy and Commerce Committee, ... Committee for recognizing the unique challenges facing long-term ... including bill language exempting Part D beneficiaries in ... proposed medication management "lock-in" provision. The SCPC has ...
Breaking Medicine Technology:EU-Arzneimittel-Richtlinie für gefälschte Medikamente; Aegate-Zusammenfassung als reale Bewertung aus Belgien 2EU-Arzneimittel-Richtlinie für gefälschte Medikamente; Aegate-Zusammenfassung als reale Bewertung aus Belgien 3SCPC Applauds Unanimous House Panel Passage of 21st Century Cures Bill Recognizing Unique Challenges Facing Long Term Care (LTC) Pharmacy Patients, Providers 2
... Colo. , Feb. 11 Mesa Laboratories, Inc. (Nasdaq: ... quarter and nine months ended December 31, 2009 . , ... Testing product line completed. Nine month cash flow provided ... 16% in the most recent six month period over the prior six ...
... , , ... Today, Siemens Healthcare announced it has renewed its ... innovative ambulatory information technology (IT) solutions. More than 35 ... tools throughout their physician networks as a result of ...
Cached Medicine Technology:Mesa Labs Reports Quarterly Sales and Earnings 2Mesa Labs Reports Quarterly Sales and Earnings 3Mesa Labs Reports Quarterly Sales and Earnings 4Mesa Labs Reports Quarterly Sales and Earnings 5Mesa Labs Reports Quarterly Sales and Earnings 6Siemens and NextGen Healthcare Renew Alliance To Deliver Ambulatory IT Solutions 2Siemens and NextGen Healthcare Renew Alliance To Deliver Ambulatory IT Solutions 3Siemens and NextGen Healthcare Renew Alliance To Deliver Ambulatory IT Solutions 4
(Date:5/22/2015)... May 22, 2015 Carnegie Science ... today announced a new partnership to develop BodyTech, a ... region. The initiative includes a new exhibit at the ... demonstration theater, and a new traveling science show, Anatomy ... of 2015. , Designed to explore a wide ...
(Date:5/22/2015)... According to a new Aegis Living Study on Attitudes ... to worry about what will happen to their memory as ... Silent Generation), which may help explain why nearly half of ... Millennials (47%), Gen X’ers (51%), and Boomers (43%). The study ... more than 2,000 U.S. adults ages 18+. , “This ...
(Date:5/22/2015)... McClean, Virginia (PRWEB) May 22, 2015 ... provider of Health IT solutions, announced today that ... ZH Healthcare is the developer of BlueEHS,a first ... (EHS). BlueEHS offers a customizable Electronic Health Records ... e-Rx, lab interfaces, a telemedicine-enabled comprehensive patient portal, ...
(Date:5/22/2015)... Gateway Building Concepts is experienced with ... the company specialize in include decks, additions, kitchen remodeling, ... and much more. , The redesigned logo is ... the company. It includes two geometrical lines that represent ... out to be used with many things associated with ...
(Date:5/22/2015)... 22, 2015 A Phase 3 ... American Society of Clinical Oncology (ASCO)’s annual meeting ... rates for those patients who received bevacizumab in ... pemetrexed/cisplatin. Bevacizumab (Avastin® Genentech, Inc.) is an antibody ... is already routinely used to treat many other ...
Breaking Medicine News(10 mins):Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 3Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 4Health News:New Study Reveals America’s Fear of Aging 2Health News:New Study Reveals America’s Fear of Aging 3Health News:ZH Healthcare Adds Bill Lane to Advisory Board 2Health News:Mesothelioma Research Organization Excited About Imminent Improvement to Standard of Care 2
... ... Same Commitment to ... the Health of all Babies, CINCINNATI, Feb. 12 ... 4-year-old Bradley,Coffey of Kennedy Heights and his family will serve as the ... for Babies is the March of Dimes premier fundraising event that,benefits all ...
... be done to help people living near major flight hubs, ... People who live near major airports may be disturbed by ... new study finds it can also boost their blood pressure ... noise, the higher blood pressure will go, the study found. ...
... Clinton, Obama, McCain, Huckabee to,Further Discuss, Outline Long ... As Democratic,presidential candidate Hillary Clinton begins her ... increasingly important March 4 Texas,primaries, the Texas Health ... both parties to go beyond the discussion of,increasing ...
... Lifesciences,Corporation (NYSE: EW ), the world leader in ... filed a patent infringement lawsuit against,CoreValve, Inc., of Irvine, ... of Delaware. The suit seeks injunctive relief and damages ... for transcatheter,heart valve technology., "Edwards has a significant ...
... 12 Ehmke,Manufacturing Company of Philadelphia was ... Agency honored 23 industry partners, customers and,individuals ... Ehmke received the Innovative Business Performer ... business (HUB) zone, small business,category. The award ...
... AOPO Coordinate Briefing on Feb. 12, ... who play a significant role in preparing ... of key,transplantation groups. The American Society of ... Network for Organ Sharing (UNOS),and Association of ...
Cached Medicine News:Health News:Local Families Chosen for Ambassador Role for 2008 March for Babies 2Health News:Local Families Chosen for Ambassador Role for 2008 March for Babies 3Health News:Airplane Noise Boosts Blood Pressure Even During Sleep 2Health News:Airplane Noise Boosts Blood Pressure Even During Sleep 3Health News:Growing Importance of March 4 Texas Primary Requires 2008 Presidential Candidates to Better Address Eldercare Financing Issues 2Health News:Edwards Lifesciences Initiates Patent Infringement Litigation Against CoreValve in the U.S. 2Health News:Defense Logistics Agency Recognizes Ehmke Manufacturing Company 2Health News:Transplant Community Unites to Educate Capitol Hill Staffers About the 'Gift of Life' 2
... Centuries of German Craftsmanship have ... in the world. Ocutek now ... Only holders of the coveted ... eight-year apprenticeship, are qualified to ...
1mm by 7mm horizontal punch. Flat serrated handle. Overall length 87mm....
Vertical punch designed to create a 1.5mm clean cylindrical hole. Rotatable for convenient positioning. Flat Handle. Overall length 87mm....
... integrated neck. Piston assembly fits into ... spring to recoil back to ready ... into precision milled cavity in platform. ... - 9.0mm. Designed for the preparation ...
Medicine Products: